93 related articles for article (PubMed ID: 41604)
1. Accumulation of N,N-dimethyltryptamine in rat brain cortical slices.
Sangiah S; Gomez MV; Domino EF
Biol Psychiatry; 1979 Dec; 14(6):925-36. PubMed ID: 41604
[TBL] [Abstract][Full Text] [Related]
2. Evidence for and against the involvement of N,N-dimethyl-tryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in schizophrenia.
Gillin JC; Wyatt RJ
Psychopharmacol Bull; 1976 Oct; 12(4):12-3. PubMed ID: 1067623
[No Abstract] [Full Text] [Related]
3. Effects of various neuroleptics, phenobarbital and SKF 525-A on dimethyltryptamine content in rat brain and liver.
Wang Lu LJ; Demetriou SK; Domino EF
Arch Int Pharmacodyn Ther; 1978 Mar; 232(1):117-33. PubMed ID: 27150
[No Abstract] [Full Text] [Related]
4. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
Dumuis A; Sebben M; Bockaert J
Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
[TBL] [Abstract][Full Text] [Related]
5. High-affinity uptake system for cysteine in crude synaptosomal fractions of rat cerebral cortex.
Misra CH
J Neurosci Res; 1980; 5(6):507-14. PubMed ID: 7205991
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the brain levels of N,N-dimethyltryptamine and alpha, alpha, beta, beta-tetradeutero-N-N-dimethyltryptamine following intraperitoneal injection. The in vivo kinetic isotope effect.
Barker SA; Beaton JM; Christian ST; Monti JA; Morris PE
Biochem Pharmacol; 1982 Aug; 31(15):2513-6. PubMed ID: 6812592
[TBL] [Abstract][Full Text] [Related]
7. N,N-dimethyltryptamine--a possible relationship to schizophrenia?
Wyatt RJ; Gillin JC; Kaplan J; Stillman R; Mandel L; Ahn HS; VandenHeuvel WJ; Walker RW
Adv Biochem Psychopharmacol; 1974; 11(0):299-313. PubMed ID: 4602668
[No Abstract] [Full Text] [Related]
8. Effects of pargyline and SKF-525A on brain N,N-dimethyltryptamine concentrations and hyperactivity in mice.
Morinan A; Collier JG
Psychopharmacology (Berl); 1981; 75(2):179-83. PubMed ID: 6798607
[TBL] [Abstract][Full Text] [Related]
9. Accumulation, subcellular localization and release of propranolol from synaptosomes of rat cerebral cortex.
Street JA; Webb JG; Bright PS; Gaffney TE
J Pharmacol Exp Ther; 1984 Apr; 229(1):154-61. PubMed ID: 6707931
[TBL] [Abstract][Full Text] [Related]
10. The significance of some biochemical abnormalities in schizophrenia.
Rodnight R
Acta Neurol (Napoli); 1975; 30(1):85-101. PubMed ID: 1063539
[No Abstract] [Full Text] [Related]
11. In vivo kinetics and displacement study of a carbon-11-labeled hallucinogen, N,N-[11C]dimethyltryptamine.
Yanai K; Ido T; Ishiwata K; Hatazawa J; Takahashi T; Iwata R; Matsuzawa T
Eur J Nucl Med; 1986; 12(3):141-6. PubMed ID: 3489620
[TBL] [Abstract][Full Text] [Related]
12. Behavioral effects and metabolic fate of N,N-dimethyltryptamine in mice pretreated with beta-diethylaminoethyl-diphenylpropylacetate (SKF 525-A), improniazid and chlorpromazine.
Shah NS; Hedden MP
Pharmacol Biochem Behav; 1978 Apr; 8(4):351-6. PubMed ID: 276891
[TBL] [Abstract][Full Text] [Related]
13. Spectral analysis of mouse EEG after the administration of N,N-dimethyltryptamine.
Morley BJ; Bradley RJ
Biol Psychiatry; 1977 Dec; 12(6):757-69. PubMed ID: 271513
[TBL] [Abstract][Full Text] [Related]
14. The in vitro identification of dimethyltryptamine (DMT) in mammalian brain and its characterization as a possible endogenous neuroregulatory agent.
Christian ST; Harrison R; Quayle E; Pagel J; Monti J
Biochem Med; 1977 Oct; 18(2):164-83. PubMed ID: 20877
[No Abstract] [Full Text] [Related]
15. [Effects of N,N-dimethyltryptamine (DMT) on tests of psychoticism (author's transl)].
Bickel P; Dittrich A; Schöpf J
Pharmakopsychiatr Neuropsychopharmakol; 1977 Jan; 10(1):10-4. PubMed ID: 329291
[TBL] [Abstract][Full Text] [Related]
16. In vivo metabolism of alpha,alpha,beta,beta-tetradeutero-N, N-dimethyltryptamine in rodent brain.
Barker SA; Beaton JM; Christian ST; Monti JA; Morris PE
Biochem Pharmacol; 1984 May; 33(9):1395-400. PubMed ID: 6587850
[TBL] [Abstract][Full Text] [Related]
17. Dose response and time course effects of N,N-dimethyltryptamine on disruption of rat shuttlebox avoidance.
Stoff DM; Moja EA; Gillin JC; Wyatt RJ
Biol Psychiatry; 1977 Jun; 12(3):339-46. PubMed ID: 266950
[TBL] [Abstract][Full Text] [Related]
18. Effects of various neuroleptics on rabbit hyperthermia induced by N, N-Dimethyltryptamine (DMT) and d-amphetamine.
Domino EF; Gahagan S; Adinoff B; Kovacic B
Arch Int Pharmacodyn Ther; 1977 Mar; 226(1):30-47. PubMed ID: 17371
[TBL] [Abstract][Full Text] [Related]
19. Naloxone enhancement of DMT and LSD-25 induced suppression of food-rewarded bar pressing behavior in the rat.
Ruffing D; Kovacic B; Demetriou S; Domino EF
Psychopharmacology (Berl); 1979 Apr; 62(3):207-10. PubMed ID: 111285
[TBL] [Abstract][Full Text] [Related]
20. Ontogeny of N,N-dimethyltryptamine and related indolealkylamine levels in neonatal rats.
Beaton JM; Morris PE
Mech Ageing Dev; 1984 Jun; 25(3):343-7. PubMed ID: 6588281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
